Carcinoma of Unknown Primary

Quick Answer

When metastatic carcinoma presents without an identified primary, FDG-PET/CT identifies the primary in roughly a quarter to a third of cases after a negative conventional work-up, and simultaneously maps the full extent of disease to guide biopsy and therapy. Yield is highest in cervical nodal metastases from an occult head-and-neck primary (tonsil/base-of-tongue), where localizing the primary changes management. A negative FDG-PET does not exclude a small or low-avidity primary, and asymmetric physiologic tonsillar/lymphoid uptake is easy to over-call.

Background

Carcinoma of unknown primary (CUP) is a histologically confirmed metastasis with no primary found after directed history, exam, imaging, and pathology (including immunohistochemistry and increasingly molecular tissue-of-origin profiling). It is biologically heterogeneous; identifying the primary can move a patient from generic to site-specific therapy and, in HPV-associated oropharyngeal presentations, into a favorable-prognosis, curable pathway.

Clinical Presentation

Common presentations: cervical adenopathy (often squamous — occult oropharynx/larynx), axillary nodes (occult breast), isolated organ metastases (liver, bone, lung), and peritoneal/nodal adenocarcinoma. History (smoking, HPV risk), exam (including guided panendoscopy of the aerodigestive tract), and IHC (e.g., p16/HPV, TTF-1, GATA3, CK7/CK20) narrow the field.

Imaging Role

• Primary detection: whole-body FDG-PET/CT finds an occult primary in a meaningful minority after standard imaging fails — most reliably for head-and-neck primaries presenting as neck nodes.
• Staging & biopsy targeting: defines disease extent and the most accessible, representative biopsy site; can redirect biopsy to a more informative lesion.
• Radiotherapy planning: in head-and-neck CUP, localizing the mucosal primary allows targeted (not whole-pharynx) irradiation.
• Complements — does not replace — histology, IHC, and molecular tissue-of-origin testing.

Interpretation & Decision

A suspicious focus should be biopsy-confirmed — FDG-PET raises pretest probability and directs the endoscopist, but physiologic head-and-neck uptake mimics tumor. In cervical-node CUP, an FDG-avid tonsil/base-of-tongue focus is the highest-yield finding. A negative scan reflects either a truly occult small primary or an FDG-low histology (some adenocarcinomas, neuroendocrine, renal, lobular breast).

Differential Diagnosis (of the FDG focus)

True mucosal primary vs physiologic asymmetric tonsillar/lymphoid, salivary, muscle, or brown-fat uptake; reactive/inflammatory nodes; and a second synchronous malignancy.

Reporting Checklist

• State the suspected primary site (if any) and recommend directed biopsy/panendoscopy.
• Map full disease extent and identify the best biopsy target.
• Explicitly caveat physiologic head-and-neck uptake and that a negative scan does not exclude a small/low-avidity primary.

Common Pitfalls

• Over-calling asymmetric physiologic tonsillar/lymphoid uptake as the primary.
• Missing FDG-low primaries (some adenocarcinomas, neuroendocrine, renal, lobular breast).
• Failing to confirm histologically before treating a PET-suspected primary.

Board Pearls

In metastatic CUP, FDG-PET/CT localizes the primary in roughly a quarter to a third of cases after negative conventional work-up, and simultaneously maps disease extent to target the most accessible, representative biopsy. Yield is highest in cervical-node CUP from an occult head-and-neck primary (tonsil/base-of-tongue), where localization changes management (and enables targeted radiotherapy).

A negative FDG-PET does not exclude a small or FDG-low primary (some adenocarcinomas, neuroendocrine, renal, lobular breast). Asymmetric physiologic tonsillar/lymphoid uptake both helps and confounds — a suspected primary needs histologic confirmation (panendoscopy/biopsy).

PET's biggest practical value is redirecting biopsy to the most informative site and defining extent; it complements, not replaces, IHC and molecular tissue-of-origin profiling. In cervical squamous CUP, p16/HPV status carries prognostic and treatment weight — an FDG-avid oropharyngeal focus in an HPV-positive patient points to a favorable, curable pathway.

Related Pages

• Tracer: FDG; disease: Head & neck cancer.

Figure / Diagram Suggestions

• A cervical-node CUP work-up algorithm (exam → PET → panendoscopy/biopsy).
• A physiologic vs pathologic tonsillar uptake teaching pair.

Self-Check